COVID-19 Vaccine: NAFDAC Advises against Use of Covifor Remidesivir

0
144
NAFDAC Director General, Professor Mojisola Adeyeye
Article1

National Agency for Food, Drug Administration and Control (NAFDAC) has warned Nigerians against the use of Covifor Remidesivir 100 mg Injection for treatment of any illness.

NAFDAC Director-General, Mojisola Adeyeye, disclosed this in a statement in Abuja.

According to her, the label on the vaccine indicates that it was “not for distribution in the United States, Canada or European Union,” thus creating suspicion about its efficacy.

READ ALSO:

Russia Delivers New Coronavirus Vaccine to Nigeria

“The product is suspicious, and it could possibly be a falsified product. The general public is hereby warned to desist from the use of such product,” Adeyeye declared.

Remdesivir is an antiviral medication currently being studied for the treatment of the Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus.

Idowu Sowunmi